[The fusion and expression of genes encoding heat-stable and heat-labile enterotoxins of escherichia coli from porcine origin]
- PMID: 16276870
[The fusion and expression of genes encoding heat-stable and heat-labile enterotoxins of escherichia coli from porcine origin]
Abstract
The genes encoding precursor heat-stabile (pro-ST) and mature peptide of B unit of heat-labile (LT) enterotoxins of Escherichia coli from piglet were amplified by polymerase chain reaction (PCR). The 3' terminus of gene encoding pro-ST was genetically fused to the 5' terminus of the LTB subunit gene in nest-PCR. The fusion genes encoding pro-ST and LTB were cloned into pGEM-T vector and subcloned into the pQE30. The recombinant plasmid was expressed in E. coli by IPTG induction. The fusion protein possessed both ST and LTB antigenicity, as well as it had lost the biological toxicity of ST or LT toxin.
Similar articles
-
Gene fusion and expression of heat-labile and heat-stable enterotoxins of enterotoxigenic Escherichia coli.Chin J Biotechnol. 1999;15(4):225-30. Chin J Biotechnol. 1999. PMID: 11037947
-
A tripartite fusion, FaeG-FedF-LT(192)A2:B, of enterotoxigenic Escherichia coli (ETEC) elicits antibodies that neutralize cholera toxin, inhibit adherence of K88 (F4) and F18 fimbriae, and protect pigs against K88ac/heat-labile toxin infection.Clin Vaccine Immunol. 2011 Oct;18(10):1593-9. doi: 10.1128/CVI.05120-11. Epub 2011 Aug 3. Clin Vaccine Immunol. 2011. PMID: 21813665 Free PMC article.
-
Construction of a nontoxic fusion peptide for immunization against Escherichia coli strains that produce heat-labile and heat-stable enterotoxins.Infect Immun. 1990 May;58(5):1159-66. doi: 10.1128/iai.58.5.1159-1166.1990. Infect Immun. 1990. PMID: 2182535 Free PMC article.
-
Development of an enterotoxigenic Escherichia coli vaccine based on the heat-stable toxin.Hum Vaccin Immunother. 2019;15(6):1379-1388. doi: 10.1080/21645515.2018.1496768. Epub 2018 Aug 21. Hum Vaccin Immunother. 2019. PMID: 30081709 Free PMC article. Review.
-
Targeting of plant-derived vaccine antigens to immunoresponsive mucosal sites.Vaccine. 2003 Jan 30;21(7-8):809-11. doi: 10.1016/s0264-410x(02)00604-7. Vaccine. 2003. PMID: 12531365 Review.